ARCHIVES

SEC Investigating Bristol-Myers’ Sales Statements

This article is from The Cancer Letter archive.

Vol. 28 No. 28 | July 12, 2002

Download PDF Visit The Full Archive

Related Articles

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

Varmus Pledges to Keep Grants at 2010 Level As Federal Shutdown Looms

April 8, 2011

FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science.

July 21, 2000

Bioassay Backlog To Be Cleared Up In Year: Squire

November 26, 1976

Only 20% of Doctors Advise CRC According To Guidelines

October 29, 2010

NCI Budget Picture: New Grants Down, No New Center Awards, Many Projects Left Unfunded

December 10, 1976